Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations

The development of resistance to previously effective treatments has been a challenge for health care providers and a fear for patients undergoing cancer therapy. This is an unfortunately frequent occurrence for patients undergoing targeted therapy for tumours harboring the activating V600E mutation...

Descripción completa

Detalles Bibliográficos
Autores principales: Obaid, Nourah Mohammad, Bedard, Karen, Huang, Weei-Yuarn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372601/
https://www.ncbi.nlm.nih.gov/pubmed/28282860
http://dx.doi.org/10.3390/ijms18030585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372601/
https://www.ncbi.nlm.nih.gov/pubmed/28282860
http://dx.doi.org/10.3390/ijms18030585

Ejemplares similares